Recent studies have suggested that the regulation of apoptosis during wound healing is important in scar establishment and development of pathological scarring. To examine the phenomenon of apoptosis and its involvement in the process of pathological scarring, we immunohistochemically quantified differential levels of expression of caspase-3 and -2, which are activated during apoptosis in vitro, in surgical resected scar tissues. We divided 33 cases of normally healed flat scars and 18 cases of pathological scars (15 cases of hypertrophic scars and 3 cases of keloid) into three groups (S1 ϭ Ͻ10 months' duration; S2 ϭ 10 to 40 months' duration; and S3 ϭ Ͼ40 months' duration) according to the duration of scar. In all three groups examined, the semiquantitative scores for caspase-3 staining were significantly higher for the combination of hypertrophic scars and keloid as a group compared with normally healed flat scars, suggesting reduced cell survival and increased apoptotic cell death in hypertrophic scars and keloid. Apoptosis and caspase proteolytic activities were examined in vitro using two flat scar-derived fibroblast lines (FSFB-1 and -2) and two keloid-derived fibroblast lines (KFB-1 and -2). After 24 hours of serum deprivation, apoptotic cells were significantly increased in both KFB lines, whereas serum deprivation of FSFB-1 cells did not result in a significant increase in apoptotic cell number. After serum deprivation, significant increases in caspase-3 proteolytic activities were detected in both KFB lines compared with both FSFB lines. In contrast, no significant differences with caspase-8 activity were observed between similarly treated KFB and FSFB lines. Furthermore, serum deprivation-induced apoptosis of KFB-2 cells was significantly inhibited by the caspase-3 inhibitor Ac-Asp-Glu-Val-Asp-fluoromethyl ketone (DEVD-FMK), indicating that caspase-3 is important for serum deprivation-induced apoptosis in KFB-2 cells. Considering the role of caspase-3 as a key effector molecule in the execution of apoptotic stimuli, our results suggested that enhanced expression of caspase-3 in hypertrophic scars and keloid induces apoptosis of fibroblasts, which may play a role in the process of pathological scarring. (Lab Invest 2000, 80:345-357).
T he cellular components of granulation tissue are mainly small vessels and inflammatory cells as well as fibroblasts and myofibroblasts. As the wound becomes epithelialized and the scar forms, there is a marked decrease in cellularity. Although previous studies have suggested some potential signals for elimination of the various populations of cells in tissue repair, little is known regarding the mechanisms of these cellular losses. The decrease in cell number with the various phases of healing is thought to be achieved by apoptosis (Greenhalgh, 1998) . There is some evidence that apoptosis is involved in the regulation of wound healing in the various phases of tissue repair. In the early phases of tissue repair, Brown et al (1997) reported that inflammatory cells underwent apoptosis starting as early as 12 hours after wounding. In the later stages of tissue repair, Desmouliere et al (1995) reported that apoptosis in myofibroblasts began on Day 12 and peaked at Day 20. Wound healing must reach an equilibrium of proliferation and apoptosis to exhibit a steady-state mature scar. In contrast, extra fibroblast activity leads to an imbalance between collagen synthesis and degradation leading to excessive scar formation. The most notable pathological forms of healing are hypertrophic scarring and keloid formation. During these processes of excessive scarring, it is conceivable that apoptosis cannot take place and the cells participating in granulation tissue are not eliminated (Desmouliere et al, 1997; Rockwell et al, 1989) . Previous studies have suggested a potential role of apoptosis in pathological forms of healing (Desmouliere et al, 1997; Greenhalgh, 1998; Rockwell et al, 1989) . Although conflicting result was obtained with regard to the level of apoptosis in keloid fibroblasts (Appleton et al, 1996; Saed et al, 1998) , it is still uncertain how deregulation of apoptosis can lead to hypertrophic scarring or keloid formation.
A death gene required for programmed cell death in Caenorhabitis elegans, Ced-3, shows significant similarity to the mammalian ice gene, which encodes the interleukin-1␤-converting enzymes (ICE) (Ellis and Horvitz, 1986; Yuan et al, 1993) . In mammalian cells, however, multiple genes encoding ICE/Ced-3 family proteases have been cloned. To date, at least 13 members of the ICE/Ced-3 family (caspases) have been identified, the majority of which, on activation, are involved in the induction and execution phases of apoptosis (Cohen, 1997; Nicholson and Thornberry, 1997) . Overexpression of various caspase family members induces apoptosis in cultured mammalian cells (Miura et al, 1993; Wang et al, 1996) . Of these cysteine proteases, caspase-3 is believed to be one of the most commonly involved in the execution of apoptosis in various cell types (Alnemri et al, 1996; Armstrong et al, 1996; Chinnaiyan et al, 1996; Enari et al, 1995) . Caspases are believed to function in a hierarchy, with caspase-8 at the apex of the cascade (Cohen, 1997) . Selective inhibitors of caspases have been constructed and examined, mainly in vitro (Livingston, 1997; Nicholson et al, 1995; Shimizu et al, 1996; Talanian et al; .
Although in vitro experiments revealed induction of apoptosis in the rat fibroblast line, Rat-1, by overexpression of the murine ICE gene (Miura et al, 1993) , limited information is available regarding the expression of caspases and the biological significance of their expression during normal wound healing (Slomiany et al, 1998) . A recent immunohistochemical study demonstrated that p53, bcl-2, and Fas are regionally expressed in keloid specimens (Wassermann et al, 1998) , whereas there have been no studies of caspase-3 expression in hypertrophic scars or keloid. Therefore, in this study, we examined differences in immunohistochemical staining of caspase-2 and -3 in pathological scars (hypertrophic scars and keloid) versus normally healed flat scars. Furthermore, we examined the functional significance of caspase-3 using keloid-derived fibroblast lines (KFB) and flat scar-derived fibroblast lines (FSFB) in vitro. This study serves as part of an effort to further examine the phenomenon of apoptosis and its role in the deregulated process of pathological scarring.
Results

Immunostaining of Caspase-3 and -2 in Normal Skin and Normally Healed Flat Scars
In normal skin, caspase-3 expression was mainly detected in the epidermis and hair follicles. Positive cells were observed in the epidermal and dermal cells, including hair follicle epithelia and sebaceous gland epithelia (Fig. 1A) . Certain endothelial cells located in the lumen of the small vessels were also positive for caspase-3 (Fig. 1C) . Although the majority of fibroblasts were not immunoreactive, a small number of fibroblasts within the papillary and reticular dermis revealed detectable levels of caspase-3 expression (Fig. 1B) . Caspase-3 positive fibroblasts were reduced in number in the part of immature scar tissue with poor cellularity and an increased deposit of collagen (Fig.  1C) . In the dermis of normally healed flat scars, slight expression of caspase-3 was detected in fibroblasts within thick collagen bundles, in which the fibroblast cellularity was low and most epidermal appendages were no longer visible (Fig. 2) . Anti-caspase-2 antibody revealed a staining pattern that was very similar to that of anti-caspase-3 antibody, although the immunoreactivity was less intense than that with anticaspase-3 antibody.
Immunostaining of Caspase-3 and -2 in Hypertrophic Scars and Keloid
In the dermis of hypertrophic scars and keloid, abundant expression of caspase-3 was detected in the hypercellular areas composed of aggregates of fibroblasts and small vessels (Fig. 3A) . These positive cells were not uniformly distributed but appeared as clusters in which the fibroblastic cellularity was high, and nodular structures were clearly visible. The characteristic dense nodular organization of collagen fibers was clearly visible in the dermis of hypertrophic scars and keloid. Immunohistochemically, caspase-3 expression observed in fibroblasts within thick collagen bundles was more abundant in keloid lesions than in hypertrophic scars (Fig. 3B ). Anti-caspase-2 antibody revealed a staining pattern that was very similar to that of anti-caspase-3 antibody, although the immunoreactivity was less intense.
Immunoreactivity Scoring of Caspase-3 and -2 in Hypertrophic Scars and Keloid
Figures 4 and 5 illustrate the immunostaining results of caspase-3 and -2, respectively. In all three groups examined, the caspase-3 staining scores were significantly higher on average for the combination of hypertrophic scars and keloid as a group than for normal flat scars (S1, 1.9 Ϯ 0.5 vs. 0.7 Ϯ 0.2; p ϭ 0.01; S2, 1.9 Ϯ 0.2 vs. 1.0 Ϯ 0.2, p ϭ 0.02; S3, 1.6 Ϯ 0.6 vs. 0.3 Ϯ 0.1, p ϭ 0.01; Fig. 4 ). Similarly, with the exception of S2, the caspase-2 staining scores were significantly higher on average for the combination of hypertrophic scars and keloid than for normal flat scars (S1, 1.9 Ϯ 0.4 vs. 0.8 Ϯ 0.2, p ϭ 0.01; S3, 1,7 Ϯ 0.3 vs. 0.5 Ϯ 0.1, p ϭ 0.04; Fig. 5 ). The average score of caspase-2 in S2 was higher for the combination of hypertrophic scars and keloid than for normal flat scars but failed to reach statistical significance (S2, 1.9 Ϯ 0.3 vs. 1.4 Ϯ 0.2, p ϭ 0.18; Fig. 5 ).
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Apoptosis and Proliferative Activity in Hypertrophic Scars and Keloid
In untreated normal skin, a few terminal deoxynucleotide transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) signal-positive cells were observed in the hair follicles and sebaceous glands, as described previously (Gavrieli et al, 1992; Kishimoto et al, 1997 ). When we examined in hypertrophic scars and keloid, certain TUNEL signal-positive fibroblasts were detected mainly in the dermis. These cells were found throughout the dermis and showed morphological changes associated with apoptosis such as the condensation of chromatin and cytoplasm (Fig. 6 ). On careful examination by electron microscopy, a few fibroblasts could be identified as apoptotic cells because of their highly condensed chromatin and discrete nuclear fragments (Fig. 7) . Some TUNEL signalpositive cells may have been inflammatory cells because of their infiltration around blood vessels. A few TUNEL signal-positive endothelial cells were also detected.
Apoptosis and proliferative activity were evaluated by determining the number of TUNEL signal-positive cells and Ki-67 positive nuclei, respectively. In S1, the average number of TUNEL-positive cells was slightly higher for hypertrophic scars and keloid than for normal healed flat scars (S1, 1.0 Ϯ 0.4 vs. 0.9 Ϯ 0.3, Immunohistochemical staining of caspase-3 in normal human skin. A, Immunostaining of caspase-3 is clearly visible in epidermal cells (arrowhead) and hair follicle epithelia (arrow). Sebaceous gland epithelia are also positive for caspase-3. B, A small number of fibroblasts (arrowhead) within the papillary and reticular dermis express caspase-3. C, Caspase-3 positive fibroblasts are reduced in number in the part of immature scar tissue with poor cellularity and an increased collagen deposition. Certain endothelial cells (arrowhead) located in the lumen of the small vessels are also positive for caspase-3. Original magnification: ϫ250 in A, ϫ500 in B, and ϫ400 in C. 
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Establishment of Keloid-derived Fibroblast Cell Lines
To confirm the immunostaining scores of caspase-3 in hypertrophic scars and keloid, we isolated two keloidderived cell lines (KFB-1 and -2) from two of three cases of keloid. In the original tissues obtained from these two cases, a few TUNEL signal-positive cells were detected in the dermis (Fig. 6 ) (mean numbers of TUNEL signal-positive cells in the original tissue of KFB-1 and -2 were 1.60 and 0.88, respectively). No positive cells were observed in the most acellular, collagenous parts of the dermis. Our immunohistochemical analysis also revealed that many cells in both of these KFB lines showed positive cytoplasmic staining with ␣-smooth muscle actin and desmin. Furthermore, many cells in both lines were generally moderately stained with 5B5 antibody (Fig. 10A) , which recognizes the prolyl 4-hydroxylase ␤ subunit expressed on fibroblasts. These results together indicate that KFB cells have certain specific features of fibroblast (Hoyhtya et al, 1984) . In addition, two FSFB lines were also stained for ␣-smooth muscle actin, desmin, and by 5B5 antibody. Fibroblast lines were used at passages 3 to 7 in the present study.
Apoptotic Changes in Keloid-derived Fibroblasts after Serum Deprivation
Twenty-four hours after serum deprivation, a small number of KFB-1 cells showed the typical features of apoptotic cells, characterized by nuclear fragmentation and chromatin condensation as assessed by Hoechst nuclear staining (Fig. 10B ). Scoring the percentage of apoptotic cells as determined by Hoechst staining indicated that serum deprivation for 24 hours significantly increased the percentage of apoptotic cells in two KFB lines compared with that in untreated these lines (KFB-1: serum-deprived cells, 9.1 Ϯ 1.7%; untreated cells, 1.4 Ϯ 0.5%; p Ͻ 0.0001; Fig. 11A ) (KFB-2: serum-deprived cells, 5.6 Ϯ 0.4%; untreated cells, 0.9 Ϯ 0.3%; p Ͻ 0.0001; Fig. 11A ), whereas no significant differences were observed in the percentage of apoptotic cells between treated and untreated cells in two FSFB lines and one normal human skin fibroblast cell line (HSFB) (Fig. 11A ). Serum deprivation for 36 hours also induced a significant increase in the number of apoptotic cells in KFB-1 cells compared with similarly treated FSFB-1 and HSFB ( p Ͻ 0.0001; Fig. 11A ). During the early stage of apoptosis, phosphatidylserine is translocated to the external surface of the membrane and the externalization is assessed by measuring the extent of fluorescein isothiocyanate (FITC)-annexin-V binding (Vermes et al, 1995) . Scoring the percentage of apoptotic cells as determined by FITC-annexin-V binding indicated that serum deprivation for 24 hours significantly increased the percentage of apoptotic cells in two KFB lines compared with that in untreated these lines (KFB-1: serum-deprived cells, 21.9 Ϯ 3.4; untreated cells, 4.5 Ϯ 1.1%; p Ͻ 0.0001; Fig. 11B ) (KFB-2: serum-deprived cells, 18.2 Ϯ 0.7%; untreated cells, 7.0 Ϯ 1.2%; p Ͻ 0.0001; Fig. 11B ). In contrast, no significant differences were observed in the percentage of apoptotic cells between treated and untreated cells in two FSFB lines and one HSFB line (Fig. 11B ).
Caspase Proteolytic Activity in Keloid-Derived Fibroblasts
To further substantiate caspase cleavage and activation in serum deprivation-induced apoptosis of KFB lines, KFB and FSFB lines were evaluated for changes in caspase-3 and -8 proteolytic activities using an enzyme fluorometric assay. After serum deprivation, significant increases in caspase-3 proteolytic activity were detected in KFB lines, with peak values exceeding those seen in similarly treated FSFB lines and reached at 5 hours after treatment (Fig. 12A) . Fivehour treatment revealed approximately 4-fold increases in caspase-3 activity in KFB-1 cells compared with similarly treated FSFB-1 cells (Fig. 12A ). In contrast, week induction of caspase-8 activity was seen in KFB-1 cells after serum deprivation, with a peak value at 4 hours after treatment exceeding that seen in FSFB-1 cells, but no significant difference was observed in caspase-8 activity between similarly treated KFB-1 and FSFB-1 cells (Fig. 12B) .
Effects of Caspase Inhibitors on Caspase Activation and Apoptosis
To obtain further evidence for the involvement of the caspase system in serum deprivation-induced apo- Immunohistochemical staining of caspase-3 in a normally healed flat scar. In the 15-month-old scar tissue, caspase-3 expression is only barely visible in fibroblasts (arrowhead) within thick collagen bundles. Original magnification: ϫ400 .
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ptosis of KFB cells, we tested the capacities of the caspase-3 inhibitor Ac-Asp-Glu-Val-Asp-fluoromethyl ketone (DEVD-FMK) and the caspase-8 inhibitor IleGlu-Thr-Asp-fluoromethyl ketone (IETD-FMK) to inhibit caspase activities in serum-deprived KFB-2 cells. As shown in Figure 13A , DEVD-FMK inhibited caspase-3 activities in a dose-dependent manner, thereby confirming the specificity of the cell lysates for DEVD-FMK. In contrast, IETD-FMK did not effectively block the activity, even when used at very high concentrations (Fig. 13B) . As the caspase-3 proteolytic activity was inhibited by DEVD-FMK, we next examined whether the inhibitor prevented serum derivationinduced apoptosis of KFB-2 cells. As shown in Figure  14 , DEVD-FMK blocked serum deprivation-induced apoptosis of KFB-2 cells in a similar concentrationdependent manner as determined by Hoechst nuclear staining. These results suggested that serum deprivation-induced apoptosis of KFB-2 cells is mediated by caspase-3.
Discussion
Another recent study of apoptosis during burn wound healing indicated that TUNEL-positive cells were detected in two different periods: the period from the Immunohistochemical staining of caspase-3 in hypertrophic scars and keloid. A, In the 13-month-old hypertrophic scar, abundant expression of caspase-3 is visible in the hypercellular area composed of aggregates of fibroblasts (arrowhead) and small vessels. B, In the 22-month-old keloid, strong expression of caspase-3 is visible in fibroblasts (arrowhead) within thick collagen bundles. Original magnification: ϫ330 in A and ϫ400 in B.
Figure 4.
Semiquantitative evaluation of caspase-3 expression by measurement of immunostaining scores in the dermis of hypertrophic scars and keloid (closed bars) and of normal healed flat scars (hatched bars). The histograms represent the average score of caspase-3 positive cells per microscopic filed. In comparison with normal healed flat scar, the immunostaining scores of caspase-3 are significantly increased in hypertrophic scars and keloid in all three groups (S1, p ϭ 0.01; S2, p ϭ 0.02; S3, p ϭ 0.01). See "Materials and Methods" for details on scoring system. The numbers (N) represent the number of scar tissue specimens examined. p Ͻ 0.05 compared with normal healed flat scars.
Figure 5.
Semiquantitative evaluation of caspase-2 expression by measurement of immunostaining scores in the dermis of hypertrophic scars and keloid (closed bars) and of normal healed flat scars (hatched bars) as outlined in Figure 4 . In S1 and S3, the immunostaining scores of caspase-2 are significantly increased in hypertrophic scars and keloid compared with normal healed flat scar (S1; p ϭ 0.01, S3; p ϭ 0.04). In S2, the average score of caspase-2 is higher for hypertrophic scars and keloid than for normal healed flat scars, but the difference is not statistically significant (p ϭ 0.18). The numbers (N) represent the number of scar tissue specimens examined. p Ͻ 0.05 compared with that of normal healed flat scars.
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Laboratory Investigation • March 2000 • Volume 80 • Number 3 acute inflammatory stage to the proliferative stage and the period from the proliferative stage to the remodelling stage (Nagata et al, 1999) . Although the mechanisms responsible for this phenomenon are presently unclear, we presumed that analysis of apoptosis in scar samples of widely different durations shows different levels of programmed cell death. Therefore, we divided our samples into three groups (S1, S2, and S3) according to the duration of scar after wounding. In the three groups examined, however, we revealed that the levels of caspase-3 expression are significantly higher in hypertrophic scars and keloid compared with normally healed flat scars. Similarly, with the exception of S2, we found that the levels of caspase-2 expression are significantly higher in hypertrophic scars and keloid compared with flat scars. The role of caspase-3 has been known to be a key effector molecule in the execution of apoptotic stimuli in vitro (Alnemri et al, 1996; Armstrong et al, 1996; Chinnaiyan et al, 1996; Enari et al, 1995) . Although the role in vivo of caspase-3 has not been determined in detail (Kuida et al, 1996; Woo et al, 1998) , we postulated that the increased expression of caspase-3 might be activated and induce a significant increase of apoptosis in hypertrophic scars and keloid. However, in S1 the number of TUNEL-positive cells is only slightly higher for the combination of hypertrophic scars and keloid than for normally healed flat scars. As reported previously, apoptosis during burn wound healing occurred during the period from the proliferative to the remodeling stage (Nagata et al, 1999) . Therefore, we speculated that the relatively high number of TUNELpositive cells in normally healed flat scars of S1 reflects the presence of remodeling to some extent, which would affect fibroblasts and endothelial cells and induce an increase in their apoptosis.
In S2 and S3, no significant differences in TUNELpositive cells were detected between normally healed flat scars and the combination of hypertrophic scars and keloid as a group. There are several possible reasons for the relatively high number of apoptotic cells in normally healed flat scars of S2 and S3. One possible reason is that here we used TUNEL staining Identification of an apoptotic cell by TUNEL staining in the 14-month-old keloid. In a TUNEL-positive fibroblast undergoing apoptosis (arrow), a highly pyknotic and shrunken nucleus is visible. Original magnification: ϫ800.
Figure 7.
Ultrastructural examination of a fibroblast undergoing apoptosis in the 22-month-old hypertrophic scar. An apoptotic fibroblast displays prominent condensed chromatin and nuclear fragmentation (arrow). Original magnification: ϫ3000. 
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as a method for assessing apoptotic cells and identified fibroblasts undergoing apoptosis in our series of scar samples. Other cell types may be affected, notably inflammatory cells, which are difficult to identify once the process of apoptosis has occurred, which may lead to the inexact identification of the cells undergoing apoptosis. In a previous study of apoptosis in the skin, Norris (1995) suggested multiple triggers of apoptosis, which work through a variety of signaling pathways. Therefore, another possible reason is that some caspase-3-independent pathway mediates the apoptosis observed in normal healed flat scars of S2 and S3. Further studies are necessary to elucidate the signal pathway that plays critical role in induction of apoptosis during wound healing.
Previous studies showed that cultured fibroblasts often exhibit characteristics typical of their in vivo phenotypes (Calderon et al, 1996; Tuan and Nichter, 1998; Yoshimoto et al, 1999; Younai et al, 1994 ). Although we described higher levels of caspase-2 and -3 expression in hypertrophic scars and keloid, Wassermann et al (1998) reported that the immunostaining levels of ICE and Fas were decreased in hypertrophic scar-derived fibroblasts. Therefore, we developed two keloid-derived fibroblast cell lines (KFB-1 and -2) from two of three keloid cases, and quantified differential levels of caspase-3 and -8 proteolytic activities between KFB and FSFB cell lines. In this study, we revealed that serum deprivation increases caspase-3 proteolytic activities in KFB cell lines, and that 5-hour treatment reveals approximately 4-fold increases in caspase-3 activity in KFB-1 cells compared with similarly treated FSFB-1 cells. Furthermore, 24-hour serum deprivation significantly increased the percentage of apoptotic cells in KFB-1 cells as compared with FSKB-1 cells. Although a conflicting result was obtained with regard to the level of apoptosis in keloid fibroblasts , our results provided evidence of a significant increase in caspase-3 proteolytic activity and apoptosis in serum-deprived keloid fibroblasts in vitro.
To further determine whether caspase-3 is a key mediator of serum deprivation-induced apoptosis of KFB cells, we pretreated each cell line with the caspase-3 inhibitor DEVD-FMK before serum deprivation. Previous studies have indicated that DEVD has specificity for caspase-3 due to its similarities to the cleavage site of the caspase-3 substrate, PARP (Fadeel et al, 1998; Gu et al, 1995; Hasegawa et al, 1996; Izban et al, 1999; Kidd, 1998; Nicholson et al, 1995; Thornberry et al, 1997) . In the present study, we have shown that the addition of DEVD-FMK after serum deprivation significantly decreases apoptosis of KFB-2, thereby confirming that caspase-3 plays an important role in serum deprivation-induced apoptosis in KFB cells.
The question of which environmental conditions make fibroblasts susceptible to apoptosis has not been resolved. A previous study indicated that serumdeprived fibroblasts transfected with c-myc undergo apoptosis when c-myc is activated (Harrington et al, 1994) . Another study indicated that c-myc, rho-p21 is also a potent inducer of apoptosis, whereas bcl-2, v-abl, E1B, and ras prevent activation of the apoptotic pathway in fibroblasts (Jimenez et al, 1995) . Recently, Ladin et al (1998) showed that clinically relevant doses of corticosteroids and interferon-␥ induce an increase in apoptosis of keloid-derived fibroblasts. Recent investigators believe that one of the triggers of apoptosis is growth factor withdrawal during differentiation (Laster et al, 1988; Moulton, 1994; Oberhammer et al, 1993; Robaye et al, 1991) . This is consistent with the present results that serum deprivation significantly increases caspase-3 proteolytic activity and apoptosis in KFB lines. As homeostasis is maintained through a balance between proliferation and cell death, subtle modifications of the microenvironment may influence the beginning of fibroblast proliferation or apoptosis. This hypothesis is supported by the in vitro data by Laster et al (1988) who showed that tumor necrosis factor (TNF)-␣ induces apoptotic and necrotic forms of cell lysis. There have been no reports regarding presence of a critical inducer of apoptosis during scarring. Recently, however, Funato et al (1997) showed that basic fibroblast growth factor (bFGF) is a potential stimulator of apoptosis in rat myofibroblasts during palatal scaring. Further studies are needed to disclose the function of bFGF as an inducer of apoptosis and the relationship to caspases, the analysis of which may shed more light on apoptotic pathway during wound healing and pathological scarring. 
Materials and Methods
Patients and Tissue Samples
A total of 51 scar samples were obtained from 47 Japanese patients (28 women and 19 men, mean age 29.7 years; range, 1-79 years) after undergoing surgical excision. The initial histological sections stained with hematoxylin and eosin were reviewed. Tissue sections from these specimens contained hypertrophic scar (n ϭ 15, mean duration 26.2 months; range, 6 -90 months), keloid (n ϭ 3, mean duration 24 months; range, 8 -36 months), or normally healed flat scar (n ϭ 33, mean duration 47.9 months; range, 0 -220 months). The hypertrophic scars or keloid were at least 6 months but less than 10 years after wounding with clinical evidence of hypertrophy including raised uniform or nodular appearance as well as erythema (Dolynchuk, 1996) . The distinction in diagnosis between keloid and hypertrophic scars was made based on clinical appearance, including the tendency of keloid to persist and extend beyond the site of the original injury and the tendency of hypertrophic scars to ultimately flatten out (Tuan and Nichter, 1998) . None of the patients had received previous treatment other than pressure garments in the past. None of the patients had complicating disease processes, such as diabetes mellitus, that might affect wound healing. Five untreated normal skin tissues were obtained from five different patients undergoing secondary control resection after tumor excision (3 women and 2 men, mean age 40 years). Informed consent was obtained from each subject. Our series of 51 scar specimens were divided into three groups according to the duration of scar after wounding: S1, less than 10 months' duration; S2, more than 10 months but less than 40 months; and S3 more than 40 months. Twenty-six cases (hypertrophic scar and keloid [6 cases], normally healed flat scar [20 cases]) were classified as S1 (mean duration 3.3 months); 16 cases (hypertrophic scar and keloid [9 cases], normally healed flat scar [7 cases]) were classified as S2 (mean duration 22.9 months); and 9 cases (hypertrophic scar and keloid [3 cases], normally healed flat scar [6 cases]) were classified as S3 (mean duration 178.0 months). Scars were routinely fixed in 10% formalin for 7 days and embedded in paraffin. Paraffin sections (6 m thick) were placed on Silane-Prep (Sigma, Poole, United Kingdom) slides and dried for 1 hour. Electron microscopy was performed on some scar tissues to analyze apoptotic bodies and other ultrastructural changes associated with apoptosis. Tissue samples taken from wounds were cut into 1-mm cubes and fixed for 5 hours at room temperature in 2% glutaraldehyde (Merck, Darmstadt, Germany) in 0.1 mol/l cacodylate buffer. They were stained in uranyl maleate for 1 hour, postfixed in osmium tetroxide, dehydrated through a graded ethanol series, and embedded in Epon (Fluka Chemie, Buchs, Switzerland).
Reagents
The anti-caspase-3 IgG 2a monoclonal antibody (MoAb) and anti-caspase-2 IgG 1 MoAb were purchased from Transduction Laboratories (Lexington, Kentucky). 5B5 MoAb and Ki-67 with the MIB-1 MoAb were obtained from Dako (Glostrup, Denmark). The caspase-3 inhibitor DEVD-FMK was purchased from Calbiochem (La Jolla, California). The caspase-8 inhibitor IETD-FMK was also obtained from Calbiochem.
Immunostaining of Caspase
Full-thickness skin and subcutaneous tissue samples were embedded in paraffin and sectioned perpendicular to the healing incision line. Sections were deparaffinized, rehydrated, and equilibrated in wash buffer solution (0.05M Tris-HCl, 0.1% Tween 20, and 0.3M NaCl) for 30 minutes at room temperature. Endogenous peroxidase activity was quenched with 0.3%
Figure 10.
A, Immunohistochemical staining on cytospin preparation of serum-deprived KFB-1 cells with 5B5 antibody. KFB-1 cells after serum deprivation for 24 hours display strong cytoplasmic positive staining. B, Morphological changes in nuclei of serum-deprived KFB-1 cells after staining with Hoechst 33258. KFB-1 cells treated with serum deprivation for 24 hours show apoptotic changes with fragmented and condensed nuclei (arrowheads). Original magnification: ϫ400 in A and ϫ500 in B.
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H 2 O 2 in methanol for 30 minutes at room temperature. Excess proteins were blocked with 5% normal rabbit serum in wash buffer solution for 30 minutes at room temperature. The primary antibodies were diluted 1: 1000 in Tris-buffered saline (TBS) and applied for 1 hour at room temperature in a humidified chamber equilibrated with phosphate-buffered saline (PBS). Antibody staining was performed with a catalyzed signal amplification (CSA) kit (Dako) containing biotinylated rabbit anti-mouse IgG and streptavidinperoxide complex. Finally, the sections were counterstained with hematoxylin, dehydrated, and mounted with Permount (Sigma).
Immunoreactivity Scoring
Two or more sections per sample were immunohistochemically stained, and 10 to 12 randomly selected fields per section were examined at ϫ200 magnification by an observer blind to the groups. As a positive internal control, we used caspase-positive basal epithelial cells. Immunostaining for caspase was evaluated as clear when staining was as intense as that of the positive internal control, and clearly positively stained cells were judged to be caspase-positive. According to the percentage of caspase-positive cells, immunostaining results were semiquantitatively scored as follows: 0, when absent; 1ϩ, when Ͻ10% of cells in the field were positive; 2ϩ, when 10% to 50% of cells in the field were positive; 3ϩ, when Ͼ50% of cells in the field were stained (Pescarmona et al, 1999) . Substitution of normal serum for primary antibodies, Induction of apoptosis in KFB lines after serum deprivation. Apoptosis was assessed by morphological analysis of apoptotic cells after staining with Hoechst 33258 (A) and by Annexin V (B) as described in "Materials and Methods." After 24 hours of serum deprivation, significant increases in the percentage of apoptotic cell are detected in both KFB lines. In contrast, serum deprivation of FSFB-1 cells does not result in a significant increase in the percentage of apoptotic cell. Cells were cultured for the indicated times (horizontal axis, time in hours). छ, KFB-1 in the absence of 10% serum; Ⅺ, KFB-2 in the absence of 10% serum; ‚, KFB-1 in the presence of 10% serum; E, KFB-2 in the presence of 10% serum; ϩ, HSFB in the presence of 10% serum; ϫ, HSFB in the absence of 10% serum; F, FSFB-1 in the presence of 10% serum; f, FSFB-1 in the absence of 10% serum.
Figure 12.
Induction of caspase-3 proteolytic activity in KFB lines after serum deprivation. Proteolytic activity was measured by cleavage of the caspase-3 specific fluorogenic substrate DEVD-pNA (A) or the caspase-8 specific fluorogenic substrate IETD-pNA (B) as described in "Materials and Methods." Cell lysates were prepared after serum deprivation for the indicated times (horizontal axis, time in hours). Significant increases in caspase-3 proteolytic activity are detected in both KFB lines compared with both FSFB lines. Five-hour serum deprivation treatment reveals approximately 4-fold increases in caspase-3 activity in KFB-1 cells compared with similarly treated FSFB-1 cells. In contrast, no significant difference with caspase-8 activity is observed between similarly treated KFB-1 and FSFB-1 cells. Ⅺ, KFB-1 in the absence of 10% serum; E, KFB-2 in the absence of 10% serum; F, KFB-2 in the presence of 10% serum; ‚, FSFB-1 in the absence of 10% serum; ϫ, FSFB-2 in the absence of 10% serum; छ, HSFB in the absence of 10% serum; ࡗ, HSFB in the presence of 10% serum.
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Laboratory Investigation • March 2000 • Volume 80 • Number 3 as a negative control, resulted in no staining of the cells. Immunostaining results were scored independently on separate days, and the average results were used for subsequent statistical analysis.
TUNEL Reaction and Ki-67 Staining
DNA fragmentation on paraffin sections of the scar tissue was analyzed by TUNEL with a commercial kit (Takara Co., Tokyo, Japan), according to the manufacturer's instructions. To confirm the staining specificity, the TUNEL procedure was modified as follows: as a positive control, sections were treated with 0.7 mg/ml DNase I (Takara) in potassium cacodylate buffer (pH 7.2) for 10 minutes before treatment with TdT (Takara). Negative controls included omission of TdT or biotinylated substrate from the buffer solution. Tonsil tissue was used as a positive control. Apoptotic cells showed positive staining in the nucleus. Proliferative activity was determined by immunostaining of Ki-67 on paraffin sections of the scar tissue. Immunostaining was performed with a CSA kit (Dako) as described above. Positive immunostaining for Ki-67 was almost completely confined to the nuclei. The extent of nuclei positive for TUNEL reaction or Ki-67 staining was analyzed by microscopy at ϫ400 magnification. Two or more sections per sample were stained, and an observer blind to the groups examined 10 to 12 randomly selected fields per section. The number of positive nuclei was calculated as the mean number of positively stained cells per field at ϫ400 magnification, and the results were used for subsequent statistical analysis.
Cell Culture
The normal human skin fibroblast cell line, HSFB, was purchased from Technoclone GmbH (DI-709, Vienna, Austria). Two flat scar-derived fibroblast cell lines, FSFB-1 and -2, were kind gifts from Ono and coworkers (Fukushima Medical College, Fukushima, Japan). All cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL, Grand Island, New York) supplemented with 10% fetal calf serum (Gibco-BRL), 2 mmol/l glutamine (Gibco-BRL), 100 U/ml penicillin (Sigma), and 100 mg/ml streptomycin (Sigma) at 37°C in a humidified atmosphere containing 5% CO 2 . Fibroblasts were used at passages 3 to 7 in this study. For caspase fluorometric assay, 1% trypsin solution was used to detach adherent cells. Preliminary experiments showed that trypsinization of fibroblasts undergoing apoptosis did not significantly affect the subsequent measurement Inhibition of caspase-3 proteolytic activity by the caspase-3 inhibitor DEVD-FMK. KFB-2 cells (3 ϫ 10 6 ) were preincubated for 6 hours with various concentrations of the caspase-3 inhibitor DEVD-FMK (A) or the caspase-8 inhibitor IETD-FMK (B) (horizontal axis, concentration in M). KFB-2 cells were then incubated in the absence of 10% serum for 6 hours in the presence of each inhibitor. DEVD-FMK inhibits caspase-3 activities in a dose-dependent manner. In contrast, IETD-FMK does not effectively block the activity, even when used at very high concentrations. Proteolytic activities using extracts from the KFB-2 cells were measured as described in "Materials and Methods."
Figure 14.
Inhibition of serum deprivation-induced apoptosis of KFB-2 cells by the caspase-3 DEVD-FMK inhibitor. KFB-2 cells (3 ϫ 10 6 ) were preincubated for 6 hours with various concentrations of DEVD-FMK (horizontal axis, concentration in M). KFB-2 cells were then incubated in the absence of 10% serum for 6 hours in the presence of the inhibitor. Apoptosis was assessed by morphological analysis after staining with Hoechst 33258. DEVD-FMK blocks serum deprivation-induced apoptosis of KFB-2 cells in a similar concentrationdependent manner.
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of DEVD-p-nitroanilide (pNA) or IETD-pNA (data not shown).
Hoechst Nuclear Staining and Annexin V Binding Assay in Cell Lines
Apoptosis was assayed by staining fibroblasts with the nuclear dye Hoechst 33258 (Bisbenzimide H 33258 Fluorochrome, Trihydrochloride; Calbiochem) at 1 mM. A minimum of 400 cells was scored for each sample and the percentages of apoptotic fibroblasts were determined. Viable and apoptotic cells revealed blue, round nuclei and blue fragmented nuclei, respectively. FITC-annexin V binding assay was performed using a commercial kit (Mebocyto Apoptosis Kit, MBL, Nagoya, Japan) from MBL (Vermes et al, 1995) . A total of 1 ϫ 10 6 cells were washed once with cold PBS (pH 7.4), collected by centrifugation, and resuspended in 1 ml of HEPES-buffered saline solution supplemented with 2.5 mM CaCl 2 2 (annexin V buffer). Then, 100 ng of annexin V-FITC and 500 ng of propidium iodide (PI) were added to 100 ml of the cell suspension (1 ϫ 10 5 cells), and the mixture was incubated for 15 minutes at room temperature. Without washing, the cells were placed in 400 ml of annexin V binding buffer and kept on ice until counting. Labeled cells were analyzed by fluorescence microscopy (Olympus BX-50, Tokyo, Japan) with laser excitation at 488 nm (reference wavelength, 530 nm). For each sample, a minimum of 400 cells was examined and the number of labeled cells was counted in a blind manner. The total number of labeled cells was summed and expressed as a percentage of the total cell number.
Caspase Activity in Cell Lines
The levels of caspase activities in four cell lines were determined using a commercial fluorometric assay kit (Caspase Colorimetric Protease Assay Kit; MBL, Nagoya, Japan), according to the manufacturer's instructions (Nicholson et al, 1995) . In this fluorometric assay, caspase-3 and -8 activities were measured by cleavage of the fluorogenic substrates respective DEVD-pNA and IETD-pNA. Detached cells (3 ϫ 10 6 ) were collected, washed three times with cold PBS, and suspended in 100 l of cell lysis buffer. Cells were incubated at 4°C for 10 minutes, then lysates were centrifuged at 15,000 rpm for 3 minutes, and cleared supernatants were collected. Fifty microliters of 2ϫ reaction buffer with 10 mmol/l DTT and 5 l of 4 mmol/l DEVD-pNA substrate or IETD-pNA substrate were added to 50 l of supernatants containing a total of 50 g of extracted proteins, followed by 1 hour of incubation in a water bath at 37°C. A control reaction of cells treated without DEVD-pNA or IETD-pNA was included. Optical density for each specimen was determined at 405 nm using a plate reader (Model 550 Microplate Reader, Bio-Rad Laboratories, Inc., Hercules, California).
Statistical Analysis
Results are expressed as means Ϯ standard errors of the mean (SEM) unless otherwise stated. Data were analyzed by ANOVA with comparisons between groups using Fisher's least significant difference method (Snedecor and Cochran, 1980) . Semiquantitative data obtained from immunohistochemical studies were expressed as median (range), and between group comparisons were analyzed using the KruskalWallis test. Analyses were performed using the Statview SEϩ Graphics package (Abacus Concepts, Berkeley, California) on an Apple Power Macintosh 7600/132 computer. A p value less than 0.05 was considered statistically significant.
